Evidence map›Paper›PMID 31417257›Full record

ArticleInternational journal of nanomedicine2019

Combinational phototherapy and hypoxia-activated chemotherapy favoring antitumor immune responses.

Beibei Ma, Jie Sheng, Ping Wang, Zhongying Jiang, Entomack Borrathybay

Open access · goldAbstract read
In one paragraph

Article in International journal of nanomedicine, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed
1.6field-weighted citation impact, top 18% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed, 28 citations in OpenAlex.

  1. Review
  2. Review
  3. Article
  4. Article
  5. Article
  6. Article
  7. Review
  8. Targeting ferroptosis in osteosarcoma.Journal of bone oncology · 2021
    Review
  9. Review
  10. Article
  11. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 1 institution in 1 country.

Beibei Ma *College of Electronic and Information Engineering, Yili Normal University, Micro-nano Electric Sensing Technology and Bionic Devices Key Laboratory, Yining 835000, People's Republic of China.
Jie Sheng *College of Electronic and Information Engineering, Yili Normal University, Micro-nano Electric Sensing Technology and Bionic Devices Key Laboratory, Yining 835000, People's Republic of China.
Ping WangCollege of Electronic and Information Engineering, Yili Normal University, Micro-nano Electric Sensing Technology and Bionic Devices Key Laboratory, Yining 835000, People's Republic of China.
Zhongying JiangCollege of Electronic and Information Engineering, Yili Normal University, Micro-nano Electric Sensing Technology and Bionic Devices Key Laboratory, Yining 835000, People's Republic of China.
Entomack BorrathybayCollege of Biology and Geography Sciences, Yili Normal University, Yining, Xinjiang, 835000, People's Republic of China.
Yili Normal University · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

PhototherapyAnimalsAntineoplastic AgentsCell DeathCell HypoxiaCell Line, TumorCell SurvivalHumansImmunotherapyIndolesLiposomesMice, Inbred BALB CNanoparticlesNeoplasmsPhotochemotherapyPolyethylene Glycols2-(2-(2-chloro-3-((1,3-dihydro-3,3-dimethyl-1-propyl-2H-indol-2-ylidene)ethylidene)-1-cyclohexen-1-yl)ethenyl)-3,3-dimethyl-1-propylindoliumAntineoplastic AgentsIndolesLiposomesPolyethylene GlycolsReactive Oxygen SpeciesTirapazamineantitumor immune responsivehypoxia-activated chemotherapyIR780metastasisphototherapytirapazamine

Identifiers

PMID31417257
PMCPMC6592097
OpenAlexW2949129253

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.